Human Genome Sciences (HGSI -1%) is the company Goldman Sachs says is most vulnerable if the...
Human Genome Sciences (HGSI -1%) is the company Goldman Sachs says is most vulnerable if the U.S. government goes into austerity mode. Other large-cap, non-defense firms that Goldman says rely on government contracts for at least 50% of revenue: GVA, HRS, FLIR, ILMN, TTEK, URS, AFFX, BRKR, ARX.
From other sites
Video at CNBC.com (May 11, 2015)
Video at CNBC.com (May 6, 2015)
Video at CNBC.com (Jan 23, 2015)
at CNBC.com (Jan 6, 2015)
Video at CNBC.com (Dec 31, 2014)
ETF Screener: Search and filter by asset class, strategy, theme, performance, yield, and much more
ETF Performance: View ETF performance across key asset classes and investing themes
ETF Investing Guide: Learn how to build and manage a well-diversified, low cost ETF portfolio
ETF Selector: An explanation of how to select and use ETFs